IBDEI10K ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17197,1,4,0)
 ;;=4^C34.92
 ;;^UTILITY(U,$J,358.3,17197,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,17198,0)
 ;;=C44.91^^73^825^1
 ;;^UTILITY(U,$J,358.3,17198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17198,1,3,0)
 ;;=3^Basal cell carcinoma of skin, unspec
 ;;^UTILITY(U,$J,358.3,17198,1,4,0)
 ;;=4^C44.91
 ;;^UTILITY(U,$J,358.3,17198,2)
 ;;=^5001092
 ;;^UTILITY(U,$J,358.3,17199,0)
 ;;=C44.99^^73^825^15
 ;;^UTILITY(U,$J,358.3,17199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17199,1,3,0)
 ;;=3^Malig Neop of skin, oth spec, unspec
 ;;^UTILITY(U,$J,358.3,17199,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,17199,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,17200,0)
 ;;=C50.912^^73^825^8
 ;;^UTILITY(U,$J,358.3,17200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17200,1,3,0)
 ;;=3^Malig Neop of lft breast, female, unspec site
 ;;^UTILITY(U,$J,358.3,17200,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,17200,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,17201,0)
 ;;=C50.911^^73^825^12
 ;;^UTILITY(U,$J,358.3,17201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17201,1,3,0)
 ;;=3^Malig Neop of rt breast, female, unspec site
 ;;^UTILITY(U,$J,358.3,17201,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,17201,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,17202,0)
 ;;=C61.^^73^825^11
 ;;^UTILITY(U,$J,358.3,17202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17202,1,3,0)
 ;;=3^Malig Neop of prostate
 ;;^UTILITY(U,$J,358.3,17202,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,17202,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,17203,0)
 ;;=C67.9^^73^825^2
 ;;^UTILITY(U,$J,358.3,17203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17203,1,3,0)
 ;;=3^Malig Neop of bladder, unspec
 ;;^UTILITY(U,$J,358.3,17203,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,17203,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,17204,0)
 ;;=C64.2^^73^825^10
 ;;^UTILITY(U,$J,358.3,17204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17204,1,3,0)
 ;;=3^Malig Neop of lft kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,17204,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,17204,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,17205,0)
 ;;=C64.1^^73^825^14
 ;;^UTILITY(U,$J,358.3,17205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17205,1,3,0)
 ;;=3^Malig Neop of rt kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,17205,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,17205,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,17206,0)
 ;;=C79.51^^73^825^4
 ;;^UTILITY(U,$J,358.3,17206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17206,1,3,0)
 ;;=3^Malig Neop of bone, secondary
 ;;^UTILITY(U,$J,358.3,17206,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,17206,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,17207,0)
 ;;=C79.52^^73^825^3
 ;;^UTILITY(U,$J,358.3,17207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17207,1,3,0)
 ;;=3^Malig Neop of bone marrow, secondary
 ;;^UTILITY(U,$J,358.3,17207,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,17207,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,17208,0)
 ;;=C44.92^^73^825^16
 ;;^UTILITY(U,$J,358.3,17208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17208,1,3,0)
 ;;=3^Squamous Cell Carcinoma of Skin,Unspec
 ;;^UTILITY(U,$J,358.3,17208,1,4,0)
 ;;=4^C44.92
 ;;^UTILITY(U,$J,358.3,17208,2)
 ;;=^5001093
 ;;^UTILITY(U,$J,358.3,17209,0)
 ;;=K63.5^^73^826^18
 ;;^UTILITY(U,$J,358.3,17209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17209,1,3,0)
 ;;=3^Colon polyp
 ;;^UTILITY(U,$J,358.3,17209,1,4,0)
 ;;=4^K63.5
 ;;^UTILITY(U,$J,358.3,17209,2)
 ;;=^5008765
 ;;^UTILITY(U,$J,358.3,17210,0)
 ;;=G56.01^^73^826^8
 ;;^UTILITY(U,$J,358.3,17210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17210,1,3,0)
 ;;=3^Carpal tunnel syndrome, right upper limb
